Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 3
1957 3
1960 3
1963 4
1964 51
1965 73
1966 99
1967 124
1968 158
1969 131
1970 141
1971 195
1972 239
1973 280
1974 371
1975 489
1976 593
1977 583
1978 725
1979 757
1980 1015
1981 990
1982 1017
1983 1164
1984 1193
1985 1323
1986 1332
1987 1305
1988 1248
1989 1482
1990 1438
1991 1420
1992 1371
1993 1371
1994 1303
1995 1239
1996 1167
1997 1147
1998 1056
1999 1049
2000 983
2001 960
2002 936
2003 913
2004 887
2005 908
2006 931
2007 960
2008 894
2009 852
2010 847
2011 824
2012 850
2013 770
2014 773
2015 777
2016 713
2017 718
2018 671
2019 695
2020 732
2021 657
2022 571
2023 562
2024 387

Text availability

Article attribute

Article type

Publication date

Search Results

47,331 results

Results by year

Filters applied: . Clear all
Page 1
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment.
Bahra A. Bahra A. Cephalalgia. 2023 Nov;43(11):3331024231214239. doi: 10.1177/03331024231214239. Cephalalgia. 2023. PMID: 37950675 Free article. Review.
Paroxysmal hemicrania and hemicrania continua are indometacin-sensitive trigeminal autonomic cephalalgias, a terminology which reflects the predominant distribution of the pain, observable cranial autonomic features and shared pathophysiology. ...Despite these characterist …
Paroxysmal hemicrania and hemicrania continua are indometacin-sensitive trigeminal autonomic cephalalgias, a terminology which reflec …
Indomethacin sustained-release?
Green JA. Green JA. Drug Intell Clin Pharm. 1984 Dec;18(12):1004-7. doi: 10.1177/106002808401801222. Drug Intell Clin Pharm. 1984. PMID: 6391883 Review.
When neither of these conditions is satisfied, then a sustained-release preparation may offer no advantages over the conventional formulation. The literature on indomethacin was examined with respect to the above conditions and it was concluded that its marketing as a sust …
When neither of these conditions is satisfied, then a sustained-release preparation may offer no advantages over the conventional formulatio …
Indomethacin.
Katz IM. Katz IM. Ophthalmology. 1981 May;88(5):455-8. doi: 10.1016/s0161-6420(81)35004-0. Ophthalmology. 1981. PMID: 7267020 No abstract available.
[Indomethacin].
Granerud ES, Munthe E. Granerud ES, et al. Tidsskr Nor Laegeforen. 1977 Apr 30;97(12):578-9. Tidsskr Nor Laegeforen. 1977. PMID: 300908 Norwegian. No abstract available.
Indomethacin in migraine.
Anthony M, Lance JW. Anthony M, et al. Med J Aust. 1968 Jan 13;1(2):56-7. doi: 10.5694/j.1326-5377.1968.tb27465.x. Med J Aust. 1968. PMID: 4867513 Clinical Trial. No abstract available.
Update on hemicrania continua.
Cittadini E, Goadsby PJ. Cittadini E, et al. Curr Pain Headache Rep. 2011 Feb;15(1):51-6. doi: 10.1007/s11916-010-0156-0. Curr Pain Headache Rep. 2011. PMID: 21080113 Free PMC article. Review.
Hemicrania continua (HC) is a rare primary headache syndrome, characterized by unilateral pain and an absolute response to indometacin. Since the term was first coined in 1984, more than 100 cases have been described worldwide. ...Functional imaging studies suggest a uniqu …
Hemicrania continua (HC) is a rare primary headache syndrome, characterized by unilateral pain and an absolute response to indometacin …
[Indomethacin in dermatology].
Meyer-Rohn J. Meyer-Rohn J. Arzneimittelforschung. 1971 Nov;21(11):1844-6. Arzneimittelforschung. 1971. PMID: 5171818 German. No abstract available.
Role of indomethacin in ductus closure: an update evaluation.
Douidar SM, Richardson J, Snodgrass WR. Douidar SM, et al. Dev Pharmacol Ther. 1988;11(4):196-212. doi: 10.1159/000457690. Dev Pharmacol Ther. 1988. PMID: 3066603 Review.
Pharmacological closure of PDA with indomethacin, a prostaglandin synthetase inhibitor is an effective drug therapy, along with usual medical treatment. ...Co-administration of furosemide with indomethacin may lessen the transient renal side effects of indomethac …
Pharmacological closure of PDA with indomethacin, a prostaglandin synthetase inhibitor is an effective drug therapy, along with usual …
Indomethacin therapy in the treatment of symptomatic polyhydramnios.
Moise KJ Jr. Moise KJ Jr. Clin Obstet Gynecol. 1991 Jun;34(2):310-8. doi: 10.1097/00003081-199106000-00012. Clin Obstet Gynecol. 1991. PMID: 1868638 Review.
It appears that maternal indomethacin therapy may be a useful adjunct in selected cases of polyhydramnios. Initial evaluation should include glucose tolerance testing and a thorough search for fetal abnormalities by ultrasonography. ...Evidence of severe constriction of th …
It appears that maternal indomethacin therapy may be a useful adjunct in selected cases of polyhydramnios. Initial evaluation should …
Systemic corticosteroids for acute gout.
Janssens HJ, Lucassen PL, Van de Laar FA, Janssen M, Van de Lisdonk EH. Janssens HJ, et al. Cochrane Database Syst Rev. 2008 Apr 16;2008(2):CD005521. doi: 10.1002/14651858.CD005521.pub2. Cochrane Database Syst Rev. 2008. PMID: 18425920 Free PMC article. Review.
Intramuscular triamcinolone acetonide was compared respectively to oral indomethacine, and intramuscular adrenocorticotropic hormone (ACTH); oral prednisolone (together with a single intramuscular diclophenac injection) was compared to oral indomethacine (together w …
Intramuscular triamcinolone acetonide was compared respectively to oral indomethacine, and intramuscular adrenocorticotropic hormone …
47,331 results
You have reached the last available page of results. Please see the User Guide for more information.